معرفی
Professor T. Hugh Jones is an Honorary Professor of Andrology at the School of Medicine and Population Health, University of Sheffield, and serves as a Consultant Physician in Diabetes and Endocrinology at Barnsley Hospital NHS Trust and as an Honorary Consultant Endocrinologist at the Royal Hallamshire Hospital in Sheffield. With over four decades of clinical and research experience, Professor Jones is recognized as a world leader in the field of testosterone deficiency research, particularly regarding its role in heart disease and diabetes pathogenesis.
Professor Jones completed his Biochemistry BSc(Hons) from 1972-1975 and his medical degree from 1975-1980 at Sheffield University. He attained MRCP(UK) in 1984 and served as a Clinical Research Fellow in the Department of Human Metabolism and Biochemistry from 1985-1988 before becoming a Lecturer in Medicine at the University of Sheffield from 1988-1993. His clinical career includes service as a Consultant Physician with special interest in Diabetes and Endocrinology at the Royal Hallamshire Hospital from 1984-1998 and at Barnsley Hospital from 1998 to the present.
Professor Jones's research has made significant contributions to understanding testosterone's role in metabolic health, being first to demonstrate that testosterone reduces insulin resistance, improves glycemic control (HbA1c), and quality of life in men with type 2 diabetes and hypogonadism. His work identified that 40% of men with Type 2 Diabetes have symptomatic testosterone deficiency. His recent publications focus on testosterone replacement therapy's effects on cardiovascular risk, bone health, inflammatory markers, and glycemic control in hypogonadal men with diabetes. His research demonstrates consistent themes of testosterone's cardioprotective effects, anti-inflammatory properties, and metabolic benefits.
- President of the Androgen Society (International) 2021-2023
- Vice President of Androgen Society 2019-2021
- Treasurer of Androgen Society 2017-2019
- Chair Academic Sub-committee Association of British Clinical Diabetologists 2014-2020
- Guideline committee Member for European Association of Urology 2015-2024
- Guideline Committee Member British Society for Sexual Medicine 2017-2023
Professor Jones has led numerous clinical trials including the TIMES2 study on testosterone replacement in hypogonadal men with metabolic syndrome and diabetes, and the STRIDE study on testosterone therapy in hypogonadal men with uncontrolled type 2 diabetes. He has served as Training Programme Director for SpR's in Diabetes and Endocrinology in South Yorkshire (1999-2010) and chaired specialist education committees for diabetes and endocrinology training. His laboratory work has investigated testosterone's mechanisms of action on vascular function, inflammation, and metabolic pathways using both clinical studies and animal models.
